EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience

Frank Rutsch, Isidro B Salusky, Carlos R Ferreira

Journal of Nephrology · 20.08.2024 · 37 (8) · 2059-2060

DOI: 10.1007/s40620-024-02057-9 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Nephrology, online erschienen am 20.08.2024. Verfasst von Frank Rutsch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics and Center for Rare Diseases, Muenster University Children's Hospital, Muenster, Germany. frank.rutsch@ukmuenster.de. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Münster.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of General Pediatrics and Center for Rare Diseases, Muenster University Children's Hospital, Muenster, Germany. frank.rutsch@ukmuenster.de.
  • Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

Förderung

  • Universitätsklinikum Münster

Zitieren

APA

Rutsch, F., Salusky, I. B., & Ferreira, C. R. (2024). Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience. Journal of Nephrology, 37(8), 2059-2060. https://doi.org/10.1007/s40620-024-02057-9

Vancouver

Rutsch F, Salusky IB, Ferreira CR. Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience. Journal of Nephrology. 2024;37(8):2059-2060. doi:10.1007/s40620-024-02057-9

BibTeX
@article{Rutsch2024,
  author = {Rutsch, Frank and Salusky, Isidro B and Ferreira, Carlos R},
  title = {Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience},
  journal = {Journal of Nephrology},
  year = {2024},
  volume = {37},
  number = {8},
  pages = {2059--2060},
  doi = {10.1007/s40620-024-02057-9}
}
Kostenlos starten →